Ceapro Inc V.CZO

RE:RE:"...assess different market capitalization initiatives..."

[prophetoffactz]

"- please explain how it makes sense that Ceapro made it onto the TSX Venture 50 based on their criteria.
"The 2023 TSX Venture 50 winners were selected based on year-over-year performance across three equally-weighted criteria: growth in market capitalization, share price appreciation and value traded for the year ended December 31, 2022."

Alternatively Sir, please explain how Ceapro's market cap was $4,738,811 as at December 31, 2021."

--------

Just like you made a mistake in claiming product volume didn't increase in 2022 the TSX-V made a mistake in calculating the market cap on Dec. 31, 2022. Mistakes happen. 

Here's the TSV-V table: TSX_Venture50_2023_Winners_List_en.pdf (dgr53wu9i7rmp.cloudfront.net)

As I've been saying we are before certain opportunity defining valuation catalysts for the pipeline. Where is your analysis of the upside? That CZO is now discussing market capitalization initiatives and corporate opportunities to unlock value before these catalysts is a much more interesting issue than a mistake for an award that doesn't matter going forward. Who is going to get rich off discussing the TSX-V award anymore? Keep focused...

"...assess different market capitalization initiatives..."

•  CZO news release, "In pursuing our objective to successfully position Ceapro as a biopharmaceutical company, the Company expects to advance these projects using our cash on hand while continuing our discussions to assess different market capitalization initiatives and corporate opportunities to unlock value,” commented Gilles Gagnon, M.Sc., MBA, President and CEO."

 

• Investopedia, "Market capitalization refers to how much a company is worth as determined by the stock market. It is defined as the total market value of all outstanding shares."